• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biol Chem . SARS-CoV-2 envelope protein mitochondrial localization reveals host metabolic disruption

tetano

Editor, Senior Moderator
J Biol Chem


. 2026 Mar 31:111419.
doi: 10.1016/j.jbc.2026.111419. Online ahead of print.
SARS-CoV-2 envelope protein mitochondrial localization reveals host metabolic disruption

Emily A David[SUP] 1 [/SUP], Elijah J Bass[SUP] 2 [/SUP], Hannah M Woods[SUP] 2 [/SUP], Daniel Stephenson[SUP] 3 [/SUP], Kellyann Román-Cruz[SUP] 2 [/SUP], Charles E Chalfant[SUP] 4 [/SUP], Robert V Stahelin[SUP] 5 [/SUP]


Affiliations
Free article Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped virus that encodes four structural proteins, including the small transmembrane envelope (E) protein. While E is known to function in viral assembly and egress, it contributes to host cell dysfunction and disease severity. We demonstrate that SARS-CoV-2 E localizes to host cell mitochondria and alters mitochondrial structure, metabolism, and redox homeostasis. Using fluorescence microscopy, we observed that E forms tubular cytoplasmic structures that colocalize with mitochondria and ceramide-rich domains. Lipidomic analysis revealed that E expression leads to reductions in cardiolipin, phosphatidylcholine, and lysophospholipids. Mitochondrial membrane potential was decreased in E-expressing cells, consistent with disrupted electron transport chain (ETC) activity, which was further supported by mitochondria stress testing via Seahorse. Despite increased mitochondrial reactive oxygen species (ROS), E did not trigger apoptosis, suggesting containment of oxidative stress within the organelle. Metabolomic profiling revealed decreased levels of key glycolytic and tricarboxylic acid (TCA) cycle intermediates, along with altered glutathione and sulfur metabolism. Notably, glutamine levels increased, potentially to compensate for reduced 2-oxoglutarate. Together, these findings suggest that E protein localizes to the mitochondria, perturbs lipid and metabolic homeostasis, and promotes ROS retention without inducing cell death. This mitochondrial dysfunction may support a shift toward aerobic glycolysis, facilitating viral replication. Our study highlights an underappreciated role for E in modulating host metabolism.

Keywords: SARS-CoV-2; cellular localization; envelope protein; membrane potential; metabolism; mitochondria; reactive oxygen species.

 
Back
Top